# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE

A. 510(k) Number: k061838   
B. Purpose for Submission: New Device   
C. Measurand: Calibrator for Calcium (CA), Cholesterol (CHOL), Creatinine (CREA), Glucose (GLU), Lactic Acid (LA), Magnesium (MG), Thyroxine (T4), Thyronine Uptake (TU), Blood Urea Nitrogen (BUN) and Uric Acid (URCA).   
D. Type of Test: Not Applicable   
E. Applicant: Dade Behring, Inc.   
F. Proprietary and Established Names: Dimension Vista Chemistry 1Calibrator, (KC110)

G. Regulatory Information:

<table><tr><td>Product Code</td><td>Classification</td><td>Regulation Section</td><td>Panel</td></tr><tr><td>Calibrator,</td><td rowspan="3">Class I</td><td>21 CFR 862.1150,</td><td>75 Clinical</td></tr><tr><td>Multi-Analyte</td><td>Calibrator.</td><td>Chemistry (CH)</td></tr><tr><td>Mixture (JIX)</td><td></td><td></td></tr></table>

# H. Intended Use:

1. Intended use(s): See indications(s) for use below.

2. Indication(s) for use:

The CHEM 1 CAL is an in vitro diagnostic product for the calibration of Calcium (CA), Cholesterol (CHOL), Creatinine (CREA), Glucose (GLU), Lactic Acid (LA), Magnesium (MG), Thyroxine (T4), Thyronine Uptake (TU), Blood Urea Nitrogen (BUN) and Uric Acid (URCA) methods on the Dimension Vista™ System.

3. Special conditions for use statement(s): For prescription use

4. Special instrument requirements: Dimension Vista™ System

# I. Device Description:

CHEM 1 CAL is a liquid, multi-analyte, bovine serum albumin based product containing calcium, cholesterol, creatinine, glucose, lactic acid, magnesium, thyroxine, urea nitrogen and uric acid. The kit consists of six vials, three vials of Calibrator A, and three vials of Calibrator B which are ready for use (no preparation is required). The volume per vial is $2 . 5 ~ \mathrm { m L }$ .

# J. Substantial Equivalence Information:

<table><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Device</td><td colspan="5" rowspan="1">Predicate Devices</td></tr><tr><td colspan="1" rowspan="1">Item</td><td colspan="1" rowspan="1">DimensionVistaTMSystemChemistry1Calibrator2</td><td colspan="1" rowspan="1">CHEM ICalibratork860021(URCA-k862359)</td><td colspan="1" rowspan="1">ChemistryICalibratork861700</td><td colspan="1" rowspan="1">CholesterolCalibrator k861700</td><td colspan="1" rowspan="1">ThyroxineCalibratork862359</td><td colspan="1" rowspan="1">ThyronineUptakeCalibratork862359</td></tr><tr><td colspan="1" rowspan="1">Form</td><td colspan="1" rowspan="1">Liquid.</td><td colspan="1" rowspan="1">Lyophilized.</td><td colspan="1" rowspan="1">Liquid.</td><td colspan="1" rowspan="1">Lyophilized</td><td colspan="1" rowspan="1">Lyophilized.</td><td colspan="1" rowspan="1">Lyophilized.</td></tr><tr><td colspan="1" rowspan="1">Traceability</td><td colspan="1" rowspan="1">BUN - NISTSRM 9122CA - NISTSRM 915.CHOL -Abell-Kendall</td><td colspan="1" rowspan="1">BUN-NIST SRM912CA - NISTSRM 915.</td><td colspan="1" rowspan="1">MG - NISTSRM 929A</td><td colspan="1" rowspan="1">CHOL -NIST SRM911.</td><td colspan="1" rowspan="1">T4 -ThyroxineMasterPool.</td><td colspan="1" rowspan="1">TU-ThyronineUptakeMasterPool.</td></tr><tr><td colspan="1" rowspan="1">EY</td><td colspan="1" rowspan="1">EY</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Device</td><td colspan="5" rowspan="1">Predicate Devices</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">(CDC-NCEP).CREA-NIST SRM914. GLU-NIST SRM917.LA-Lactic acid -lithium saltA-Grade.MG - NISTSRM 929A.T4 -USP.TU-Calculatedvalue.URCA-NIST SRM913.</td><td colspan="1" rowspan="1">CREA -NIST SRM914. GLU -NIST SRM917. LA -Lactic acidlithium saltA-Grade.URCA -NIST SRM913.</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Matrix</td><td colspan="1" rowspan="1">Bovineserumalbuminbasedproduct.</td><td colspan="1" rowspan="1">Bovineserumalbuminbasedproduct.</td><td colspan="1" rowspan="1">Puremagnesiumdissolved ina diluteSolution ofHCL,reagentgradepotassiumdihydrogenphosphateand reagentgradeglycerol.</td><td colspan="1" rowspan="1">Bovineserumalbuminbasedproduct.</td><td colspan="1" rowspan="1">Humanserum basedproduct.</td><td colspan="1" rowspan="1">Humanserum basedproduct.</td></tr><tr><td colspan="1" rowspan="1">Number ofLevels</td><td colspan="1" rowspan="1">Two levels.</td><td colspan="1" rowspan="1">Threelevels.</td><td colspan="1" rowspan="1">Three levels.</td><td colspan="1" rowspan="1">Threelevels.</td><td colspan="1" rowspan="1">Five levels.</td><td colspan="1" rowspan="1">Five levels.</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

<table><tr><td>STANDARDS</td></tr><tr><td>Title and Reference Number</td></tr><tr><td>Stability Testing of In Vitro Diagnostic Reagents (13640)</td></tr><tr><td>Medical devices - Application of risk management to medical devices (14971:2000)</td></tr><tr><td colspan="4" rowspan="1">GUIDANCE</td></tr><tr><td colspan="1" rowspan="1">Document Title</td><td colspan="1" rowspan="1">Office</td><td colspan="1" rowspan="1">Office Division</td><td colspan="1" rowspan="1">Web Page</td></tr><tr><td colspan="1" rowspan="1">Guidance for Industry -Abbreviated 510(k)Submissions for In VitroDiagnostic Calibrators; Final</td><td colspan="1" rowspan="1">OIVD</td><td colspan="1" rowspan="1">−</td><td colspan="1" rowspan="1">http://www.fda.gov/cdrh/ode/calibrator.html</td></tr><tr><td colspan="1" rowspan="2">Guidance for Industry andFDA Staff - Use of Symbolson Labels and in Labeling ofIn Vitro Diagnostic DevicesIntended for Professional Use</td><td colspan="1" rowspan="2">b</td><td colspan="1" rowspan="2">b</td><td colspan="1" rowspan="1">http://www.fda.gov/cdrh/ocd/guidance/4444.html</td></tr><tr><td colspan="1" rowspan="1"></td></tr></table>

L. Test Principle: Not Applicable

# M. Performance Characteristics (if/when applicable):

1. Analytical performance:

a. Precision/Reproducibility: Not Applicable

b. Linearity/assay reportable range: Not Applicable

c. Traceability, Stability, Expected values (controls, calibrators, or methods):

Traceability: The assigned values of the Chemistry 1 Calibrator were verified on a Dimension $\textsuperscript { \textregistered }$ Vista™ System calibrated with an approved Master Pool. Master Pool values were assigned on multiple Dimension $\textsuperscript { \textregistered }$ clinical chemistry instruments. According to the sponsor the traceability of the assigned values of the Chemistry 1 Calibrator was standardized to the below table of assigned values.

<table><tr><td colspan="1" rowspan="1">Constituent</td><td colspan="1" rowspan="1">Traceability</td></tr><tr><td colspan="1" rowspan="1">BUN</td><td colspan="1" rowspan="1">NIST SRMa 912</td></tr><tr><td colspan="1" rowspan="1">AC</td><td colspan="1" rowspan="1">NIST SRM 915</td></tr><tr><td colspan="1" rowspan="1">CHOL</td><td colspan="1" rowspan="1">NIST SRM 911 (CDCb) Abell-Kendall referencemethod</td></tr><tr><td colspan="1" rowspan="1">CREA</td><td colspan="1" rowspan="1">NIST SRM 914</td></tr><tr><td colspan="1" rowspan="1">GLU</td><td colspan="1" rowspan="1">NIST SRM 917</td></tr><tr><td colspan="1" rowspan="1">LA</td><td colspan="1" rowspan="1">Lactic Acid Lactic acid- lithium salt (A- Grade)</td></tr><tr><td colspan="1" rowspan="1">MG</td><td colspan="1" rowspan="1">NIST SRM 929A</td></tr><tr><td colspan="1" rowspan="1">T4</td><td colspan="1" rowspan="1">USPb</td></tr><tr><td>TU</td><td>Calculated value</td></tr><tr><td>URCA</td><td>NIST SRM 913</td></tr></table>

1 National Institute of Standards and Technology – Standard Reference Material. b CDC: Centers for Disease Control c United States Pharmacopeia.

Stability: The target shelf life for the Dimension Vista $\textsuperscript { \textregistered }$ Chemistry 1 Calibrator is 12 months. A vial punctured by the instrument and stored on board has a stability claim of one day. An open vial not stored on the instrument, but recapped and stored in a refrigerator has a stability claim of 30 days. Stability study protocols and acceptance criteria were described and found to be acceptable.

d. Detection limit: Not applicable e. Analytical specificity: Not applicable

f. Assay cut-off: Not applicable

2. Comparison studies:

a. Method comparison with predicate device: Not applicable

b. Matrix comparison: Not applicable

3. Clinical studies:

a. Clinical Sensitivity: Not applicable

b. Clinical specificity: Not applicable

c. Other clinical supportive data (when a. and b. are not applicable):

4. Clinical cut-off: Not applicable

5. Expected values/Reference range: Not applicable

N. Proposed Labeling: The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# O. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.